Skip to content

A Clinical Cohort Study on the Efficacy Evaluation of Short-Term Epidural Electrical Stimulation in the Treatment of Cervical Spinal Cord Injury.

A Clinical Cohort Study on the Efficacy Evaluation of Short-Term Epidural Electrical Stimulation in the Treatment of Cervical Spinal Cord Injury.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095515
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury

Interventions

Test group (implantation of short-range epidural electrical stimulator):NA
Control group (without implantation of short-term epidural electrical stimulator):NA

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients of acute traumatic spinal cord injury aged between 18 and 75 years; 2. The ASIA grade ranges from A to C; 3. Receiving posterior laminectomy, decompression and internal fixation within 72 hours post-injury; 4. Continuing rehabilitation treatment for no less than 3 months after the operation; 5. Capable of cooperating with the standardized neurological examination in accordance with the ISNCSCI standard (encompassing patients on ventilators), and being both willing and able to engage in the follow-up of this research study, with a follow-up duration of a minimum of 1 year.

Exclusion criteria

Exclusion criteria: 1. Spinal infections or tumors; 2. Skin infections in the vicinity of the surgical site; 3. Immune system deficiency disorders; 4. Other existing surgical contraindications; 5. Abnormalities in routine blood tests: white blood cell count < 3×10?/L, neutrophil count < 1.5×10?/L, platelet count < 50×10?/L; 6. Currently afflicted with relatively severe chronic ailments, metabolic conditions (such as diabetes), neurological and psychiatric maladies as well as neurotransmitter-linked diseases (like epilepsy, Parkinson's disease, etc.), active hemorrhagic patients, those with severe hypertension, severe thrombocytopenia, and hyperkalemia; 7. Concurrent severe craniocerebral injury with a GCS score of <= 8; 8. Pre-existing neurological disorders that impact patients' limb movement; 9. Peripheral nerve injuries due to trauma, interfering with the assessment of patients' limb function.

Design outcomes

Primary

MeasureTime frame
American Spinal Injury Association impairment scale;Spinal Cord Independence Measure;EMS;Waiking Index for Spinal Cord Injury;Japanese Orthopaedic Association Scores;

Countries

China

Contacts

Public ContactJin Fan

Jiangsu Province Hospital

fanjin@njmu.edu.cn+86 136 4518 2875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026